JMP Securities Upgrades Allergen (AGN) to Market Outperform

Article Related Press Releases (1) Related Articles (2) Stock Quotes (1) Comments (0)

JMP Securities upgraded Allergen (NYSE: AGN) from Market Perform to Market Outperform with a price target of $135.00 following Q4 results.

For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.

Shares of Allergen closed at $106.70 yesterday, with a 52 week range of $81.28-$107.69.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
• RBC Capital Upgrades TETRA Technologies Inc. (TTI) to Outperform
• New Study Reveals Workers Around the World are Unprepared for Retirement

Create E-mail Alert Related Categories

Upgrades

Related Entities

JMP Securities

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?